Lincoln Pharmaceuticals gets nod for scheme of amalgamation

20 Sep 2019 Evaluate

Lincoln Pharmaceuticals has received approval for scheme of amalgamation between Lincoln Parenteral and Lincoln Pharmaceuticals. The proposed amalgamation intend and seek to achieve flexibility and integration of size, scale and financial strength. The Board of Directors of the Company at its meeting held on September 19, 2019 has approved the same.

Lincoln Pharmaceuticals is engaged in the manufacture and marketing of affordable therapeutic products. The product range of the company includes Tablets, Capsules, Injectable, Syrups and Ointments.

Lincoln Pharma Share Price

459.90 7.05 (1.56%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×